We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Consumer Discretionary 9.92%
3 Healthcare 7.34%
4 Financials 7.06%
5 Communication Services 6.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RFP
4476
CALL
DELISTED
Resolute Forest Products Inc.
RFP
$155K ﹤0.01%
13,000
KLTR icon
4477
Kaltura
KLTR
$249M
$153K ﹤0.01%
+14,846
New +$175K
NEXT icon
4478
NextDecade
NEXT
$1.96B
$153K ﹤0.01%
55,294
+25,137
+83% +$79.3K
GLAD icon
4479
Gladstone Capital
GLAD
$448M
$152K ﹤0.01%
6,733
-13,840
-67% -$318K
AONCW
4480
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$152K ﹤0.01%
220,646
+158,482
+255% +$127K
EQOS
4481
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$152K ﹤0.01%
+46,774
New +$237K
ESPR
4482
PUT
DELISTED
Esperion Therapeutics
ESPR
$151K ﹤0.01%
+12,500
New +$182K
CRHC.WS
4483
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$151K ﹤0.01%
166,666
HIMS icon
4484
Hims & Hers Health
HIMS
$7.25B
$150K ﹤0.01%
19,849
-143,602
-88% -$1.22M
ZY
4485
DELISTED
Zymergen Inc. Common Stock
ZY
$150K ﹤0.01%
+11,416
New +$242K
FMIVW
4486
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
$149K ﹤0.01%
+136,915
New +$156K
PANA
4487
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$148K ﹤0.01%
+15,196
New +$150K
FOXW
4488
DELISTED
FoxWayne Enterprises Acquisition Corp. Class A Common Stock
FOXW
$148K ﹤0.01%
+14,964
New +$148K
EAR
4489
DELISTED
Eargo, Inc. Common Stock
EAR
$148K ﹤0.01%
+1,101
New +$588K
POND.WS
4490
DELISTED
Angel Pond Holdings Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
POND.WS
$147K ﹤0.01%
+186,327
New +$148K
GHAC
4491
DELISTED
Gaming & Hospitality Acquisition Corp. Class A Common Stock
GHAC
$146K ﹤0.01%
+14,900
New +$145K
APGB.WS
4492
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$145K ﹤0.01%
156,051
+96,051
+160% +$106K
SLAMW
4493
DELISTED
Slam Corp. warrant
SLAMW
$144K ﹤0.01%
+159,816
New +$171K
ARYD
4494
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$144K ﹤0.01%
+14,270
New +$144K
LFMD icon
4495
LifeMD
LFMD
$151M
$142K ﹤0.01%
+22,822
New +$195K
MPX
4496
DELISTED
Marine Products Corp
MPX
$142K ﹤0.01%
+11,366
New +$166K
JUGGW
4497
DELISTED
Jaws Juggernaut Acquisition Corporation Warrant
JUGGW
$142K ﹤0.01%
+119,591
New +$140K
AGGRW
4498
DELISTED
Agile Growth Corp Warrant
AGGRW
$142K ﹤0.01%
218,353
+162,798
+293% +$130K
MLCO icon
4499
PUT
Melco Resorts & Entertainment
MLCO
$2.08B
$141K ﹤0.01%
+13,800
New +$182K
OSBC icon
4500
Old Second Bancorp
OSBC
$1.29B
$141K ﹤0.01%
+10,779
New +$129K

Similar funds

David Shaw's Q3 2021 Portfolio in Review

As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, David Shaw opened a new position in Sea Limited worth $206M.

  • David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • David Shaw opened 915 new positions and closed 695 in Q3 2021.
  • David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.